PHARMACEUTICAL CAMOMILE PRODUCT

摘要

Process for producing a pharmaceutical camomile product wherein flowers of the tetraploid camomile variety Manzana containing at least 150 mg % of chamazulene and at least 300 mg % of (-)- alpha -bisabolol, other bisaboloids amounting to less than 50 mg %, are harvested at a stage of growth when only 30 to 70% of the tubular florets of the flower head are open and dried at an air temperature not higher than 50 DEG C.